Recursion Pharmaceuticals Names New Chief Medical Officer

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Recursion names Vicki Goodman as CMO

Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in ...
Investing

Recursion names Vicki Goodman as chief medical officer

SALT LAKE CITY - Recursion (NASDAQ:RXRX) announced Monday that Vicki Goodman, M.D., will become Chief Medical Officer effective April 6, 2026, replacing David Mauro, M.D., Ph.D., who is transitioning ...